Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 23:11:696.
doi: 10.3389/fphys.2020.00696. eCollection 2020.

Neuregulin, an Effector on Mitochondria Metabolism That Preserves Insulin Sensitivity

Affiliations
Review

Neuregulin, an Effector on Mitochondria Metabolism That Preserves Insulin Sensitivity

Anna Gumà et al. Front Physiol. .

Abstract

Various external factors modulate the metabolic efficiency of mitochondria. This review focuses on the impact of the growth factor neuregulin and its ErbB receptors on mitochondria and their relationship with several physiopathological alterations. Neuregulin is involved in the differentiation of heart, skeletal muscle, and the neuronal system, among others; and its deficiency is deleterious for the health. Information gathered over the last two decades suggests that neuregulin plays a key role in regulating the mitochondrial oxidative machinery, which sustains cell survival and insulin sensitivity.

Keywords: ErbB receptors; diabetes; insulin resistance; mitochondria; neuregulin; obesity.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Protective actions of neuregulin on different tissues. Neuregulin, acting locally or as an endocrine factor, protects against metabolic stress and inflammation in a manner that is tightly linked to mitochondria function. Schematic art pieces used in this figure were provided by Servier Medical Art (http://servier.com/Powerpoint-image-bank). Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License.

Similar articles

Cited by

References

    1. Alimandi M., Romano A., Curia M. C., Muraro R., Fedi P., Aaronson S. A., et al. (1995). Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10 1813–1821. - PubMed
    1. Altiok N., Bessereau J. L., Changeux J. P. (1995). ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate. EMBO J. 14 4258–4266. 10.1002/j.1460-2075.1995.tb00100.x - DOI - PMC - PubMed
    1. Baar K., Wende A. R., Jones T. E., Marison M., Nolte L. A., Chen M., et al. (2002). Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J. 16 1879–1886. 10.1096/fj.02-0367com - DOI - PubMed
    1. Bach D., Pich S., Soriano F. X., Vega N., Baumgartner B., Oriola J., et al. (2003). Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 278 17190–17197. 10.1074/jbc.M212754200 - DOI - PubMed
    1. Belmonte F., Das S., Sysa-Shah P., Sivakumaran V., Stanley B., Guo X., et al. (2015). ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity. Am. J. Physiol. Heart Circ. Physiol. 309 H1271–H1280. 10.1152/ajpheart.00517.2014 - DOI - PMC - PubMed